Vaccines and Disease-Modifying Antirheumatic Drugs Practical Implications for the Rheumatologist

被引：47

作者：

Friedman, Marcia A. ^{[1
]}

Winthrop, Kevin L. ^{[2
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Rheumatol, Mail Code OP09,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA

[2] Oregon Hlth & Sci Univ, Dept Infect Dis, 840 SW Gaines Rd, Portland, OR 97239 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2017年 / 43卷 / 01期

关键词：

Vaccine; Rheumatoid arthritis; DMARD; Biologic; Anti-TNF; Rituximab; Immunogenicity; Efficacy; NECROSIS-FACTOR-ALPHA; B-VIRUS REACTIVATION; PNEUMOCOCCAL POLYSACCHARIDE VACCINATION; ADVISORY-COMMITTEE; ANTIBODY-RESPONSE; HERPES-ZOSTER; IMMUNIZATION PRACTICES; IMMUNE-RESPONSE; ARTHRITIS PATIENTS; INFLUENZA VACCINE;

D O I：

10.1016/j.rdc.2016.09.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with rheumatoid arthritis are highly vulnerable to infections because of abnormalities in their immune system, and because of immunosuppressive effects of their medications. Vaccinations in this population are complicated by disease-modifying antirheumatic drugs, which also modulate or suppress the immune system and potentially decrease the immunogenicity and efficacy of the vaccines. We review the available data regarding the impact of rheumatoid arthritis therapy on the immunogenicity of various common vaccines. We also review rheumatoid arthritis specific vaccination recommendations, live vaccine safety concerns, and current gaps in our understanding of these issues."

引用

页码：1 / +

页数：14

共 50 条

[41] Tapering of disease-modifying antirheumatic drugs: an overview for daily practice
Maassen, Johanna Maria
van Ouwerkerk, Lotte
Aliaart, Cornelia Francina
LANCET RHEUMATOLOGY, 2021, 3 (09): : E659 - E670
[42] Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators
Moreira, P. M.
Correia, A. M.
Cerqueira, M.
Gil, M. F.
ARP RHEUMATOLOGY, 2022, 1 (03): : 218 - 224
[43] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - POTENTIAL EFFECTS IN OLDER PATIENTS
GARDNER, G
FURST, DE
DRUGS & AGING, 1995, 7 (06) : 420 - 437
[44] Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry
Munoz-Martinez, C.
Segura-Puertas, M.
Gomez-Moreno, G.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2834 - 2842
[45] Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis
Lin, ATH
Clements, PJ
Furst, DE
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) : 409 - +
[46] Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators
Pinho, A. M.
Duarte, C.
Ferreira, R. J. O.
ARP RHEUMATOLOGY, 2023, 2 (02): : 177 - 178
[47] The Relationship Between Autoimmune Disease and Disease-Modifying Antirheumatic Drugs on Wound Healing
Kirloskar, Kunal M.
Dekker, Paige K.
Kiene, Julianne
Zhou, Suzanne
Bekeny, Jenna C.
Rogers, Ashley
Zolper, Elizabeth G.
Fan, Kenneth L.
Evans, Karen K.
Benedict, Carol Deane
Pasieka, Helena B.
Attinger, Christopher E.
ADVANCES IN WOUND CARE, 2022, 11 (12) : 650 - 656
[48] Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
Kavanaugh, Arthur
van Vollenhoven, Ronald
Muram, David
Alam, Jahangir
Arora, Vipin
Correia, Ana-Luisa de Macedo Pinto
de la Torre, Inmaculada
O'Dell, James
Faraawi, Rafat
JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 891 - 891
[49] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OPTIONS FOR MYOSITIS IN UK CLINICAL PRACTICE
Prieto, Cristina Parraga
Galloway, James
Ming, Caroline
Chinoy, Hector
Gordon, Patrick
RHEUMATOLOGY, 2015, 54 : 123 - 123
[50] A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs
Van Roon, EN
Wu, M
Idzinga, F
Van den Bernt, PMLA
Jansen, TLTH
Houtman, NM
Van de Laar, MAFJ
Wilffert, B
Brouwers, JRBJ
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 462 - 462

← 1 2 3 4 5 →